These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19541840)

  • 1. p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.
    Rivetti di Val Cervo P; Tucci P; Majid A; Lena AM; Agostini M; Bernardini S; Candi E; Cohen G; Nicotera P; Dyer MJ; Melino G
    Blood; 2009 Jun; 113(25):6498-9; author reply 6499-500. PubMed ID: 19541840
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
    Sampath D; Calin GA; Puduvalli VK; Gopisetty G; Taccioli C; Liu CG; Ewald B; Liu C; Keating MJ; Plunkett W
    Blood; 2009 Apr; 113(16):3744-53. PubMed ID: 19096009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells.
    Kubo N; Okoshi R; Nakashima K; Shimozato O; Nakagawara A; Ozaki T
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):405-11. PubMed ID: 21093410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.
    Levy D; Adamovich Y; Reuven N; Shaul Y
    Cell Death Differ; 2007 Apr; 14(4):743-51. PubMed ID: 17110958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch.
    Oberst A; Malatesta M; Aqeilan RI; Rossi M; Salomoni P; Murillas R; Sharma P; Kuehn MR; Oren M; Croce CM; Bernassola F; Melino G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11280-5. PubMed ID: 17592138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase cleavage of Itch in chronic lymphocytic leukemia cells.
    Rossi M; Inoue S; Walewska R; Knight RA; Dyer MJ; Cohen GM; Melino G
    Biochem Biophys Res Commun; 2009 Feb; 379(3):659-64. PubMed ID: 19073138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulatory circuit controlling Itch-mediated p73 degradation by Runx.
    Levy D; Reuven N; Shaul Y
    J Biol Chem; 2008 Oct; 283(41):27462-27468. PubMed ID: 18701449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of p63 by Itch.
    Melino G; Knight RA; Cesareni G
    Cell Cycle; 2006 Aug; 5(16):1735-9. PubMed ID: 16931910
    [No Abstract]   [Full Text] [Related]  

  • 10. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
    Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
    Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two faces of p73.
    Grob TJ; Fey MF; Tobler A
    Cell Death Differ; 2002 Mar; 9(3):229-30. PubMed ID: 11859403
    [No Abstract]   [Full Text] [Related]  

  • 12. MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function.
    Wu H; Leng RP
    Oncotarget; 2015 Aug; 6(25):21479-92. PubMed ID: 26025930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 expression and function in vestibular schwannoma.
    Ahmad ZK; Altuna X; Lopez JP; An Y; Wang-Rodriguez J; Juneja VR; Chen JS; Arandazi MJ; Aguilera J; Harris JP; Ongkeko WM
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):662-9. PubMed ID: 19620587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [P53-independent apoptosis through a novel ATM/IKK-alpha/p73-mediated apoptotic pathway].
    Ozaki T; Nakagawara A
    Seikagaku; 2008 May; 80(5):409-13. PubMed ID: 18575226
    [No Abstract]   [Full Text] [Related]  

  • 15. p73: regulator in cancer and neural development.
    Irwin MS; Miller FD
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S17-22. PubMed ID: 15153941
    [No Abstract]   [Full Text] [Related]  

  • 16. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
    Park GB; Kim YS; Kim D; Kim S; Lee HK; Cho DH; Lee WJ; Hur DY
    J Immunol; 2013 Dec; 191(12):6281-91. PubMed ID: 24249729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 - constitutively open for business.
    Seeliger MA; Moll UM
    Cell Death Differ; 2013 Aug; 20(8):972-3. PubMed ID: 23832148
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells.
    Freebern WJ; Smith JL; Chaudhry SS; Haggerty CM; Gardner K
    J Biol Chem; 2003 Jan; 278(4):2249-55. PubMed ID: 12427762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors.
    Boominathan L
    Mol Cancer; 2007 Apr; 6():27. PubMed ID: 17407586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.